{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T10:55:58Z","timestamp":1758279358600,"version":"3.44.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Netherlands Heart Foundation","award":["2001.005"],"award-info":[{"award-number":["2001.005"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.clinbiochem.2018.06.009","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T21:22:17Z","timestamp":1529356937000},"page":"31-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Insulin resistance involvement in prevalence of familial dysbetalipoproteinemia in \u03b52\u03b52 subjects by Bayesian network modeling"],"prefix":"10.1016","volume":"59","author":[{"given":"James P.","family":"Corsetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanzy M.","family":"Love","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles E.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan J.L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin P.F.","family":"Dullaart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0005","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0022-2275(20)32417-2","article-title":"Pathogenesis of type III hyperlipidemia (dysbetalipoproteinemia): questions, quandaries, and paradoxes","volume":"40","author":"Mahley","year":"1999","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0010","first-page":"49","article-title":"Apolipoprotein E and familial dysbetalipoproteinemia: clinical, biochemical, and genetic aspects","volume":"4","author":"Smelt","year":"2004","journal-title":"Semantic Vasc. Med."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/10408363.2013.870526","article-title":"Dysbetalipoproteinemia: a mixed hyperlipidemia of remnant lipoproteins due to mutations in apolipoprotein E","volume":"51","author":"Marais","year":"2014","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/MOL.0000000000000192","article-title":"Dysbetalipoproteinemia: an extreme disorder of remnant metabolism","volume":"26","author":"Marais","year":"2015","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.clinbiochem.2017.11.010","article-title":"Roles of high apolipoprotein E blood levels and HDL in development of familial dysbetalipoproteinemia in \u03b52\u03b52 subjects","volume":"52","author":"Corsetti","year":"2018","journal-title":"Clin Biochem."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0030","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s001090050227","article-title":"Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia","volume":"76","author":"Brummer","year":"1998","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0035","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1161\/01.ATV.19.11.2722","article-title":"Severe hyperlipidemia in apolipoprotein E2 homozygotes due to combined effect of hyperinsulinemia and an SstI polymorphism","volume":"19","author":"Sijbrands","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0040","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/hq0202.102919","article-title":"Expression of type III hyperlipoproteinemia in apolipoprotein E2 (Arg158\u2192Cys) homozygotes is associated with hyperinsulinemia","volume":"22","author":"de Beer","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.artmed.2003.11.001","article-title":"Bayesian networks in biomedicine and health-care","volume":"30","author":"Lucas","year":"2004","journal-title":"Artif. Intell. Med."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0050","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jbi.2003.09.022","article-title":"Bayesian networks for knowledge discovery in large datasets: basics for nurse researchers","volume":"36","author":"Lee","year":"2003","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jbi.2007.07.003","article-title":"Prognostic Bayesian networks I: rationale, learning procedure, and clinical use","volume":"40","author":"Verduijn","year":"2007","journal-title":"J. Biomed. Inform."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0060","series-title":"Proceedings of the 28th IEEE Engineering in Medicine and Biology Conference. New York","first-page":"205","article-title":"Bayesian networks for cardiovascular monitoring","author":"Roberts","year":"2006"},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0065","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/CIRCULATIONAHA.109.865501","article-title":"Integrative predictive model of coronary artery calcification in atherosclerosis","volume":"120","author":"Mcgeachie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2016.04.017","article-title":"Influences on plasminogen activator inhibitor-2 polymorphism-associated recurrent cardiovascular disease risk in patients with high HDL cholesterol and inflammation","volume":"250","author":"Corsetti","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0075","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1681\/ASN.V11101882","article-title":"Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population","volume":"11","author":"Pinto-Sietsma","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0080","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.metabol.2011.11.010","article-title":"Apolipoprotein E predicts incident cardiovascular disease risk in women but not men with concurrently high levels of high-density lipoprotein cholesterol and C-reactive protein","volume":"61","author":"Corsetti","year":"2012","journal-title":"Metab. Clin. Exp."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0085","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2362.2010.02287.x","article-title":"Inflammation reduces HDL protection against primary cardiac risk","volume":"40","author":"Corsetti","year":"2010","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0090","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting glucose and insulin concentration in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0095","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/(SICI)1096-9136(1998120)15:12<1031::AID-DIA705>3.0.CO;2-6","article-title":"Apolipoprotein E genotype is a determinant of low-density lipoprotein cholesterol and its response to a low-cholesterol diet in type 1 diabetic patients with elevated urinary albumin excretion","volume":"15","author":"Blaauwwiekel","year":"1998","journal-title":"Diabet. Med."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0100","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/ncpendmet0982","article-title":"A diagnostic algorithm for the atherogenic apolipoprotein B dyslipidemias","volume":"4","author":"de Graaf","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"year":"2007","series-title":"Measuring Connection Strengths and Link Strengths in Discrete Bayesian Networks","author":"Ebert-Uphoff","key":"10.1016\/j.clinbiochem.2018.06.009_bb0105"},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0110","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.1073\/pnas.93.25.14788","article-title":"Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility","volume":"93","author":"Weng","year":"1996","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0115","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2337\/diabetes.50.3.643","article-title":"Studies with apolipoprotein A-II transgenic mice indicate a role for HDLs in adiposity and insulin resistance","volume":"50","author":"Castellani","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0120","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1194\/jlr.M400345-JLR200","article-title":"Mechanisms mediating insulin resistance in transgenic mice overexpressing mouse apolipoprotein A-II","volume":"45","author":"Castellani","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0125","doi-asserted-by":"crossref","first-page":"11633","DOI":"10.1074\/jbc.M708995200","article-title":"Apolipoprotein A-II is a regulator of very low density lipoprotein metabolism and insulin resi2008stance","volume":"283","author":"Castellani","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/07853890.2011.573498","article-title":"Apoliprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis","volume":"44","author":"Chan","year":"2012","journal-title":"Ann. Med."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0135","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.RES.0000075600.87675.16","article-title":"Biochemical and genetic association of plasma apolipoprotein A-II levels with familial combined hyperlipidemia","volume":"92","author":"Hooman","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0140","doi-asserted-by":"crossref","first-page":"E1352","DOI":"10.1210\/jc.2013-1680","article-title":"Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study","volume":"98","author":"Abbasi","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0145","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1074\/jbc.273.28.17483","article-title":"Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins","volume":"273","author":"Huang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0150","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.ATV.16.1.149","article-title":"Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects","volume":"16","author":"Cohn","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0155","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/ATVBAHA.109.198226","article-title":"Human apolipoprotein A-II determines plasma triglyceride by regulating lipoprotein lipase activity and high-density lipoprotein proteome","volume":"30","author":"Julve","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0160","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacl.2007.07.006","article-title":"Diagnosis of type III hyperlipoproteinemia from plasma total cholesterol, triglyceride, and apolipoprotein B","volume":"1","author":"Sniderman","year":"2007","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/(SICI)1098-2272(1997)14:3<283::AID-GEPI6>3.0.CO;2-6","article-title":"Genetics of type III hyperlipoproteinemia","volume":"14","author":"Feussner","year":"1997","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0170","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jacl.2013.05.003","article-title":"Resequencing the APOE reveals that rate mutations are not significant contributory factors in the development of type III hyperlipidemia","volume":"7","author":"Evans","year":"2013","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0175","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ejhg.2008.202","article-title":"The expression of type III hyperlipoproteinemia: involvement of lipolysis genes","volume":"17","author":"Henneman","year":"2009","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2018.06.009_bb0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/2047-783X-16-2-79","article-title":"Cerebrovascular atherosclerosis in Type III hyperlipidemia is modulated by variation in the apolipoprotein A5 gene","volume":"16","author":"Evans","year":"2011","journal-title":"Eur. J. Med. Res."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912018302236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912018302236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:52:46Z","timestamp":1757865166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912018302236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":36,"alternative-id":["S0009912018302236"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.06.009","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin resistance involvement in prevalence of familial dysbetalipoproteinemia in \u03b52\u03b52 subjects by Bayesian network modeling","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}